BRD2 and breast cancer: Ibrahim et al. [61] collected three blood samples from patients with BC at three different times: baseline before the beginning of NAT, after four cycles of adriamycin/cyclophosphamide (inter-treatment), and after 12 doses of weekly paclitaxel.